Resources

This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services.

A fact sheet for frontline health workers about mental health support.

This alert contains regular updates for disability service providers about the COVID-19 vaccination rollout.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 9 April 2021.

This update outlines the issues involved in the delays to the opt in process for the Bonded Medical Program.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 8 April 2021.

Guidelines for the Refundable Accommodation Deposit (RAD) Support Loan Program, which provides zero interest loans to eligible residential aged care providers. The guidelines include relevant information on the RAD Support Loan Program, including eligibility and how to apply.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 7 April 2021.

This implementation plan details the actions we will take to implement the Partnership Reformulation Program. This includes stakeholder engagement, risk management strategies, the monitoring and reporting framework and considerations for evaluation.

This communique is for the meetings of the Advisory Committee on Health Emergency Response to Coronavirus (COVID-19) for People with Disability on 7 April 2021.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 6 April 2021,

This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 5 April 2021.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 4 April 2021,

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 3 April 2021.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 2 April 2021.

The ATAGI 2021 Annual Statement on Immunisation is the first publication in this series. It covers key successes, trends and challenges in the use of vaccines and control of vaccine-preventable diseases in 2020. It also signals ATAGI’s priority actions for addressing key issues for 2021 and beyond.

This infographic issued on 1 April 2021 provides a weekly traffic light report of the coronavirus (COVID-19) situation across Australia.

This infographic provides a quick view of the coronavirus (COVID-19) situation in Australia on 1 April 2021.

This fact sheet provides information for participants of the Australian Thalidomide Survivors Support Program about the categories of goods and services which are eligible to be claimed under the Extraordinary Assistance Fund (EAF).

This form is a template for health practitioners to provide evidence to support an eligible thalidomide survivor (patient) to receive support from the Extraordinary Assistance Fund (EAF) or the Health Care Assistance Fund (HCAF).

This fact sheet provides information about how participants of the Australian Thalidomide Survivors Support Program can make a claim to the Extraordinary Assistance Fund (EAF). The EAF helps cover the costs of goods and services to assist with activities of daily living.

This document provides a quick overview of the current situation in New Zealand, including case numbers and quarantine-free travel criteria, as at 31 March 2021.

This fact sheet provides information about how participants of the Australian Thalidomide Survivors Support Program can make a claim to the Health Care Assistance Fund (HCAF). The HCAF helps cover out-of-pocket health care expenses incurred as a direct result of thalidomide injuries.